iHD group | CVVH group | P value | ||
---|---|---|---|---|
( n = 128) | ( n = 122) | |||
Survival at 14 days after RRT | 39.5% | 43.9% | 0.81a | |
14-day mortality rate | 43.6% | 37.8% | 0.63a | |
30-day mortality rate | 52.4% | 45.4% | 0.60a | |
All-cause intrahospital mortality rate (last contact) | 60.3% | 54.6% | 0.72a | |
Days until death | 15.6 ± 44.5 | 18.5 ± 48.9 | 0.71 | |
Days until death on ICU | 15.5 ± 45.9 | 18.4 ± 50.0 | 0.73 | |
Days until hospital discharge (in survivors) | 51.2 ± 47.1 | 48.7 ± 49.7 | 0.78 | |
Days in ICU | 25.2 ± 40.1 | 22.3 ± 26.1 | 0.50 | |
Days in hospital | 33.9 ± 49.3 | 32.4 ± 37.4 | 0.79 | |
Suspected reason for death (multiple possible) | Cardiac failure | 31 | 22 | 0.42a |
Pulmonary failure | 39 | 31 | 0.59a | |
Sepsis | 56 | 45 | 0.55a | |
CNS | 7 | 6 | 0.92a | |
Hemorrhagy | 5 | 4 | 0.93a | |
Withdrawal of therapy | 4 | 2 | 0.74a | |
Days on RRT | 17.2 ± 37.1 | 13.7 ± 17.9 | 0.35 | |
Dialysis-free days | 4.2 ± 9.6 | 3.1 ± 9.0 | 0.38 | |
RRT switch (number of patients) | 25 (19.5%) | 56 (45.9%) | 0.002a | |
Number of patients on RRT (% of survivors, days after ICU admission) | At 21 days | 20 (32.3%) | 20 (29.9%) | 0.97a |
At 60 days | 14 (26.4%) | 13 (22.8%) | 0.90a | |
Serum creatinine at hospital discharge/last contact (in survivors; mg/dl) | 2.18 ± 1.8 | 2.12 ± 1.7 | 0.85 | |
Total days on vasopressors | 4.3 ± 3.7 | 4.5 ± 3.7 | 0.75 | |
Cumulative vasopressor dose (g) | Epinephrine | 0.70 | 0.64 | 0.96 |
Norepinephrine | 19.1 | 18.5 | 0.30 | |
Dobutamine | 150.2 | 137.9 | 0.56 | |
Total days on mechanical ventilation | 8.1 ± 8.8 | 7.2 ± 6.5 | 0.34 | |
Total fluid balance (L) | 20.5 ± 23.2 | 24.9 ± 28.4 | 0.19 |